... CNS Effects. The CNS effects that are reported with the fluoroquinolones are dizziness, headache, and insomnia. The only quinolone ...

... DISCUSSION: The reported neurotoxic effects of the fluoroquinolones include insomnia, seizures, delirium, and psychosis, best explained by the gamma ...

... During therapy with fluoroquinolones adverse CNS reactions such as dizziness, light-headedness, insomnia or sleepiness are observed in up to 20% of patients. ...

... are associated with fewer severe side effects than fluoroquinolones, and they ... Within 2 days developed joint pain (severe in hands), insomnia, severe agitation ...

... linked with fluoroquinolones: musculoskeletal problems such as tendinitis, tendon rupture and joint pain, and central nervous system problems such as insomnia, ...

... account the expanded antimicrobial spectrum of the newer fluoroquinolones and their ...or hepatic impairment (patients with severe disease), Insomnia (13 percent ...

... followed by CNS (headache, restlessness, dizziness, insomnia), allergic, photosensitivity ... The safety of fluoroquinolones in childhood and pregnancy is debated ...

... Broad Spectrum Fluoroquinolones are effective against more than 90 percent of the ...central nervous system problems (such as dizziness, insomnia and confusion ...

... In general, fluoroquinolones can cause gastrointestinal side effects, skin rashes, and central nervous system disturbances (eg, dizziness, insomnia, confusion ...

... (Peripheral Neuropathy Associated with Fluoroquinolones, Jay S. Cohen, The ... chest pain; nervousness, anxiety; insomnia, trouble sleeping; tremor; rapid heartbeat; ...

Krcmery S, Hromec J, Tvrdikova M, Hassan M, Gulla D.
Newer quinolones in the long term prophylaxis of recurrent urinary tract infections (UTI).
Drugs. 1999;58 Suppl 2:99-102. Review.
PMID: 10553716 [PubMed - indexed for MEDLINE]

Lipsky BA, Dorr MB, Magner DJ, Talbot GH.
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Clin Ther. 1999 Jan;21(1):148-59.
PMID: 10090432 [PubMed - indexed for MEDLINE]

Henry D, Ellison W, Sullivan J, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
Antimicrob Agents Chemother. 1998 Sep;42(9):2262-6.
PMID: 9736546 [PubMed - indexed for MEDLINE]

Stahlmann R, Schwabe R.
Safety profile of grepafloxacin compared with other fluoroquinolones.
J Antimicrob Chemother. 1997 Dec;40 Suppl A:83-92. Review.
PMID: 9484877 [PubMed - indexed for MEDLINE]

Kisicki JC, Griess RS, Ott CL, Cohen GM, McCormack RJ, Troetel WM, Imbimbo BP.
Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Antimicrob Agents Chemother. 1992 Jun;36(6):1296-301.
PMID: 1329618 [PubMed - indexed for MEDLINE]

Norrby SR.
Side-effects of quinolones: comparisons between quinolones and other antibiotics.
Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):378-83. Review.
PMID: 1864300 [PubMed - indexed for MEDLINE]